<DOC>
	<DOC>NCT00542607</DOC>
	<brief_summary>No information was yet available over the effect of levocetirizine in children under 12 years. The aim of this double-blind, placebo-controlled study was to assess the efficacy and safety of levocetirizine in children from 6 to 12 years old with perennial allergic rhinitis due to house dust mites.</brief_summary>
	<brief_title>Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<criteria>adults 18 to 55 years both inclusive suffering at least 2 years of seasonal allergic rhinitis due to grass pollen positive RAST and/or positive skin prick test comply with study restrictions known alcohol or drug addiction or abuse known allergy/intolerance to lactose, cellulose, cornstarch presence of nasal anatomical deformities leading to &gt; 50% obstruction ENT infection within 30 days of the study use of disallowed medication ongoing desensitization known cardiac, renal or hepatic dysfunction presenting allergic bronchial asthma use of cimetidine intending to donate blood during the trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levocetirizine dihydrochloride</keyword>
	<keyword>Xyzal tablets</keyword>
</DOC>